Aditxt stock.

Find out all the key statistics for Aditxt, Inc. (ADTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...

Aditxt stock. Things To Know About Aditxt stock.

While the stock has been plunging for a while now, ADTX stock is grabbing investors attention in the meantime after the company effected a reverse spl Aditxt, Inc. (NASDAQ: ADTX) is a promising biotech company with a main focus of developing technologies that improve the health of the immune system. While the stock has been plunging for a while ... Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...Key Data. Open $3.5000. Day Range 3.3000 - 3.5765. 52 Week Range 3.2727 - 76.4000. Market Cap $1.55M. Shares Outstanding 441.85K. Public Float 189.2K. Beta 1.06. Rev. per Employee $12.29K.Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity …08/31/2023 - 07:00 PM . RICHMOND, Va.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an …

Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

NASDAQ:ADTX - Aditxt Stock Price, News & Analysis S&P 500 4,550.43 DOW 35,333.47 QQQ Is Microsoft the NVIDIA Killer? [Investor Alert] Potential …Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. ...

Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business. Update Webinar on April 14 th. Richmond, Virginia - April 5, 2022 - Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX) has entered into a revenue-sharing agreement with Cellvera, and certain of its affiliates. The agreement is designed …Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Aditxt Stock Forecast FAQ What is ADTX's revenue growth forecast for 2023-2024? ( NASDAQ : ADTX ) Aditxt 's forecast annual revenue growth rate of 521% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06% , and it is also forecast to beat the US market's average forecast revenue growth rate of 7.51% .Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 27, 2023 · Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic ...

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune …

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock (or pre-funded warrant in lieu thereof) at a purchase price of $10.00 ...

Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... Key Data. Open $3.5000. Day Range 3.3000 - 3.5765. 52 Week Range 3.2727 - 76.4000. Market Cap $1.55M. Shares Outstanding 441.85K. Public Float 189.2K. Beta 1.06. Rev. per Employee $12.29K.Track Aditxt Inc (ADTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Aditxt, Inc. (ADTX) latest earnings report: revenue, EPS, surprise, history, news and analysis.Item 1.01. Entry into a Material Definitive Agreement. On December 20, 2022, Aditxt, Inc. (the "Company"), entered into an At The Market Offering Agreement (the "ATM Agreement") with H.C. Wainwright & Co., LLC as agent (the "Agent"), pursuant to which the Company may offer and sell, from time to time through the Agent, shares of the Company's common stock, par value $0.001 per share (the ...Aditxt, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise certain Series C warrants to purchase shares of the Company's common stock ...

Investors in Aditxt, Inc. ADTX need to pay close attention to the stock based on moves in the options market lately.That is because the Sep 17, 2022 $2.50 Call had some of the highest implied ...Item 1.01. Entry into a Material Definitive Agreement. On December 20, 2022, Aditxt, Inc. (the "Company"), entered into an At The Market Offering Agreement (the "ATM Agreement") with H.C. Wainwright & Co., LLC as agent (the "Agent"), pursuant to which the Company may offer and sell, from time to time through the Agent, shares of …Aditxt reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always ...Find out all the key statistics for Aditxt, Inc. (ADTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...Aditxt, Inc. is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops …Nov 30, 2023 · Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. Aditxt has an Altman Z-Score of -31.71 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Aditxt, Inc. (ADTX) stock, including valuation metrics, financial numbers, share information and more.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune …SEC Filings – Aditxt, Inc. ... SEC Filings

Aditxt reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always ...189,204 Yield ADTX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) Shares Sold Short 959 Change from Last 140.35% Percent of Float...While the stock has been plunging for a while now, ADTX stock is grabbing investors attention in the meantime after the company effected a reverse spl Aditxt, Inc. (NASDAQ: ADTX) is a promising biotech company with a main focus of developing technologies that improve the health of the immune system. While the stock has been plunging for a while ...28 thg 8, 2020 ... timely and fast moving immune monitoring technology coming to commercial market. #investors #stock #biotech #smallcapAditxt (ADTX) disclosed in a filing on Friday a prospectus for a common stock offering of up to 2.06M shares by selling stockholders.ADTX shares down 2% aftermarket.FilingAdditional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. ...Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. ...Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune …

Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator Gurufocus warns about four red flags impacting ADTX stock. Among them ...

Item 1.01 Entry into a Material Definitive Agreement. On March 17, 2023, Aditxt, Inc. (the "Company") entered into a consulting agreement (the "Consulting Agreement") with an independent consultant for a term of thirty days. Pursuant to the Consulting Agreement, the independent consultant agreed to provide the Company with …

Frequently Asked Questions for Aditxt, Inc. Shareholders Aditxt stock is traded on the Nasdaq Capital Market exchange under the ticker symbol ADTX, and its common stock CUSIP number is 007025505. Aditxt’s initial public offering (IPO) occurred on July 2, 2020. Vstock Transfer, LLC is Aditxt’s transfer agent. Vstock Transfer, LLC18 Lafayette Aditxt Inc (ADTX) stock is trading at $14.75 as of 10:47 AM on Thursday, Sep 28, a rise of $1.71, or 13.15% from the previous closing price of $13.04. The stock has traded between $13.33 and $24.00 so far today. Volume today is low. So far 308,003 shares have traded compared to average volume of 419,078 shares.14 hours ago ... ADTX has a roughly average overall score of 40 meaning the stock holds a better value than 40% of stocks at its current price.Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Aditxt Inc ( ADTX) is up 11.47% today. ADTX has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on ADTX! ADTX stock closed at $3.40 and is up $0.39 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Aditxt, Inc. (ADTX) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. 3.5000 0.0000 (0.00%) At close: …Aditxt, Inc. A ADTX shares are trading lower Friday after the company announced a $10 million private placement priced at-the-market under Nasdaq rules.. The Details: After the market close on Thursday, Aditxt announced that it had entered into definitive agreements for the purchase and sale of 1,000,000 shares of common stock at …While the stock has been plunging for a while now, ADTX stock is grabbing investors attention in the meantime after the company effected a reverse spl Aditxt, Inc. (NASDAQ: ADTX) is a promising biotech company with a main focus of developing technologies that improve the health of the immune system. While the stock has been plunging for a while ...

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m. Eastern Time on August 18, 2023.The stock surged over 500% Thursday, on which it once again was halted, resumed trading, and was then halted again. Aditxt is a low-float stock and is trading higher on abnormally-high volume. According to Benzinga Pro, the stock experienced above-average trading volume of 1.14 million shares on Thursday compared to its average …Find the latest analyst research for Aditxt, Inc. Common Stock (ADTX) at Nasdaq.com.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Instagram:https://instagram. future trading brokertop mt4 brokersfbgkxbest small cap growth funds Aditxt, Inc. Stock price Equities ADTX US0070256047 Biotechnology & Medical Research Market Closed ... Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ... stock mitkoptions trading sites Webull offers ADTX stock news, real time Aditxt Inc news help you invest smart. step by step how to day trade ADTX Stock Analysis: Promising Performance and Positive Outlook for Aditxt Inc. ADTX stock had a significant performance on August 31, 2023, based on the information provided. According to CNN Money, one analyst has offered a 12-month price forecast for Aditxt Inc, with a median target of $160.00. This represents a +417.46% …A. While ratings are subjective and will change, the latest Aditxt ( ADTX) rating was a maintained with a price target of $4.00 to $61.00. The current price Aditxt ( ADTX) is trading at is $3.57 ...Nov 15, 2023 · In conclusion, Aditxt Inc (ADTX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.